These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 16260190)

  • 1. Quantification of tipranavir in human plasma by high-performance liquid chromatography with UV detection.
    Giraud E; Rey E; Tréluyer JM; Pons G; Jullien V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):86-90. PubMed ID: 16260190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method.
    D'Avolio A; Sciandra M; Siccardi M; Baietto L; de Requena DG; Bonora S; Di Perri G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):374-8. PubMed ID: 17092784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction.
    Colombo S; Béguin A; Marzolini C; Telenti A; Biollaz J; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):138-43. PubMed ID: 16359932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High performance liquid chromatographic method for the determination of HIV-1 protease inhibitor tipranavir in plasma of patients during highly active antiretroviral therapy.
    Langmann P; Heinz W; Klinker H; Schirmer D; Guhl C; Leyh M; Winzer R
    Eur J Med Res; 2008 Feb; 13(2):52-8. PubMed ID: 18424362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of darunavir (TMC114) in human plasma by high-performance liquid chromatography with ultra-violet detection.
    Goldwirt L; Chhun S; Rey E; Launay O; Viard JP; Pons G; Jullien V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):327-31. PubMed ID: 17706473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
    Crommentuyn KM; Rosing H; Hillebrand MJ; Huitema AD; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 May; 804(2):359-67. PubMed ID: 15081931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
    Choi SO; Rezk NL; Kashuba AD
    J Pharm Biomed Anal; 2007 Mar; 43(4):1562-7. PubMed ID: 17236737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An efficient HPLC method for the quantitative determination of atazanavir in human plasma suitable for bioequivalence and pharmacokinetic studies in healthy human subjects.
    Müller AC; Kanfer I
    J Pharm Biomed Anal; 2010 Sep; 53(1):113-8. PubMed ID: 20395105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple high performance liquid chromatography assay for monitoring plasma concentrations of tipranavir in HIV infected patients.
    Dailly E; Reliquet V; Victorri-Vigneau C; Raffi F; Jolliet P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):317-20. PubMed ID: 16497564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
    Elens L; Veriter S; Di Fazio V; Vanbinst R; Boesmans D; Wallemacq P; Haufroid V
    Clin Chem; 2009 Jan; 55(1):170-4. PubMed ID: 19028822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatographic assay for the non-peptidic protease inhibitor tipranavir in plasma.
    Sparidans RW; Dost F; Crommentuyn KM; Huitema AD; Schellens JH; Beijnen JH
    Biomed Chromatogr; 2006 Aug; 20(8):671-3. PubMed ID: 16799929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of atazanavir in human plasma using solid-phase extraction and high-performance liquid chromatography.
    Cateau E; Tournier N; Dupuis A; Le Moal G; Venisse N
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):791-5. PubMed ID: 15927437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of tipranavir in human plasma by reverse phase liquid chromatography with UV detection using photodiode array.
    Keil K; Difrancesco R; Morse GD
    Ther Drug Monit; 2006 Aug; 28(4):512-6. PubMed ID: 16885718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection.
    Chhun S; Rey E; Tran A; Lortholary O; Pons G; Jullien V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):223-8. PubMed ID: 17306633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection.
    Lamotte C; Peytavin G; Farinotti R
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 735(2):159-70. PubMed ID: 10670732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple determination of the HIV protease inhibitor atazanavir in human plasma by high-performance liquid chromatography with UV detection.
    Loregian A; Pagni S; Ballarin E; Sinigalia E; Parisi SG; Palù G
    J Pharm Biomed Anal; 2006 Oct; 42(4):500-5. PubMed ID: 16765009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous quantitation of etoricoxib, salicylic acid, valdecoxib, ketoprofen, nimesulide and celecoxib in plasma by high-performance liquid chromatography with UV detection.
    Pavan Kumar VV; Vinu MC; Ramani AV; Mullangi R; Srinivas NR
    Biomed Chromatogr; 2006 Jan; 20(1):125-32. PubMed ID: 16013036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction.
    Colombo S; Guignard N; Marzolini C; Telenti A; Biollaz J; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(1):25-34. PubMed ID: 15358304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantification of lopinavir and ritonavir in human plasma by high performance liquid chromatography coupled with UV detection.
    Kou H; Ye M; Fu Q; Han Y; Du X; Xie J; Zhu Z; Li T
    Sci China Life Sci; 2012 Apr; 55(4):321-7. PubMed ID: 22566088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detection.
    Cattaneo D; Maggiolo F; Ripamonti D; Perico N
    J Chromatogr Sci; 2008 Jul; 46(6):485-9. PubMed ID: 18647467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.